Panbela Therapeutics, Inc. (PBLA) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts PBLA Hot Sheet
Join SI Premium – FREE
Panbela Therapeutics, Inc. (NASDAQ: PBLA) reported Q3 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Panbela Therapeutics, Inc. (PBLA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Worthington Industries (WOR) Misses Q4 EPS by 9c
- William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
